Matches in SemOpenAlex for { <https://semopenalex.org/work/W4253347950> ?p ?o ?g. }
- W4253347950 endingPage "4746" @default.
- W4253347950 startingPage "4738" @default.
- W4253347950 abstract "Abstract The hybrid gene BCR-ABL that typifies chronic myeloid leukemia (CML) represents an attractive target for therapy with antisense oligodeoxyribonucleotides (ODN). A central obstacle in the therapeutic application of ODN is their poor cellular uptake. Adding various lipophilic conjugates to the ODN backbone has been reported to improve uptake, and electroporation of target cells has also been shown to enhance intracellular ODN delivery. We have shown that (1)BCR-ABL–directed ODN will specifically decrease the level ofBCR-ABL mRNA, provided that cells are first permeabilized with Streptolysin-O (SL-O), and (2) chimeric methylphosphonodiester:phosphodiester ODN directed against 9 bases either side of the BCR-ABL junction are more efficient ODN effectors than structures composed solely of phosphodiester or phosphorothioate linkages. In this study, we compared the efficacy of lipophilic conjugation, SL-O permeabilization and electroporation on the intracellular delivery and molecular effect ofBCR-ABL–directed ODN. b2a2- and b3a2-directed chimeric ODN were synthesized either unmodified or with one of the following groups at the 5′ end: cholesterol, vitamin E, polyethylene glycol of average molecular weight 2,000 or 5,000, N-octyl-oligo-oxyethylene, or dodecanol. ODN associated with Lipofectin was also studied. Comparison was made in untreated, electroporated, and SL-O permeabilized KYO1 cells. Uptake was examined by fluorescence microscopy and flow cytometry, using ODN structures that were 3′ labeled with fluorescein. The effect on target BCR-ABL mRNA expression was analyzed by Northern blotting. Several conjugated structures associated avidly with the cell membrane without achieving significant intracellular uptake or molecular effect. Similarly, ODN:Lipofectin complexes moderately increased cell association, without enhancing intracellular levels of ODN or inducing detectable molecular effect. In SL-O permeabilized or electroporated cells, uptake was approximately 1 to 2 logs greater than in untreated cells, and rapid nuclear localization was seen, especially with unmodified chimeric ODN. In SL-O permeabilized cells treated with ODN directed to the b2a2 and b3a2 junctions respectively, b2a2 BCR-ABL mRNA levels at 4 hours were reduced to 2.6% ± 2.1% and 38.4% ± 1.3% of control values. In cells permeabilized by electroporation, BCR-ABL mRNA levels were decreased to 4.0% ± 1.4% of control levels by b2a2 directed ODN, although very little nontargeted suppression was seen with b3a2-targeted ODN (93.4% ± 4.2% of control). Greater cell to cell variation in ODN uptake was seen for SL-O permeabilized cells when compared with electroporated cells, suggesting that, after SL-O permeabilization, relatively unpermeabilized and overpermeabilized populations may coexist. No structure had any effect on the level of irrelevant (p53, MYC, and GADPH) mRNA levels. We conclude that the conjugation of chimeric ODN with one of the above-mentioned lipophilic groups or the complexing of ODN with Liopfectin does not improve either intracellular delivery of ODN or the molecular effect. In contrast, both electroporation and SL-O permeabilization (1) considerably enhanced uptake of chimeric ODN (even for structures without a conjugate group) and (2) achieved significant suppression of target mRNA levels." @default.
- W4253347950 created "2022-05-12" @default.
- W4253347950 creator A5011733008 @default.
- W4253347950 creator A5020913751 @default.
- W4253347950 creator A5025297677 @default.
- W4253347950 creator A5040757424 @default.
- W4253347950 creator A5067522555 @default.
- W4253347950 date "1998-06-15" @default.
- W4253347950 modified "2023-10-17" @default.
- W4253347950 title "Improving the Intracellular Delivery and Molecular Efficacy of Antisense Oligonucleotides in Chronic Myeloid Leukemia Cells: A Comparison of Streptolysin-O Permeabilization, Electroporation, and Lipophilic Conjugation" @default.
- W4253347950 cites W1458660061 @default.
- W4253347950 cites W1508773001 @default.
- W4253347950 cites W1733933634 @default.
- W4253347950 cites W1854073081 @default.
- W4253347950 cites W1891870429 @default.
- W4253347950 cites W1969818257 @default.
- W4253347950 cites W1987011300 @default.
- W4253347950 cites W1998919839 @default.
- W4253347950 cites W2006239014 @default.
- W4253347950 cites W2014846266 @default.
- W4253347950 cites W2020092689 @default.
- W4253347950 cites W2023769605 @default.
- W4253347950 cites W2045511459 @default.
- W4253347950 cites W2061791707 @default.
- W4253347950 cites W2064188840 @default.
- W4253347950 cites W2067355409 @default.
- W4253347950 cites W2076293478 @default.
- W4253347950 cites W2077947305 @default.
- W4253347950 cites W2090839028 @default.
- W4253347950 cites W2133446679 @default.
- W4253347950 cites W2146354013 @default.
- W4253347950 cites W2155463132 @default.
- W4253347950 cites W2174930811 @default.
- W4253347950 cites W22185118 @default.
- W4253347950 cites W2267908114 @default.
- W4253347950 cites W2395162514 @default.
- W4253347950 cites W4294216491 @default.
- W4253347950 doi "https://doi.org/10.1182/blood.v91.12.4738" @default.
- W4253347950 hasPublicationYear "1998" @default.
- W4253347950 type Work @default.
- W4253347950 citedByCount "73" @default.
- W4253347950 countsByYear W42533479502012 @default.
- W4253347950 countsByYear W42533479502013 @default.
- W4253347950 countsByYear W42533479502015 @default.
- W4253347950 countsByYear W42533479502016 @default.
- W4253347950 countsByYear W42533479502018 @default.
- W4253347950 countsByYear W42533479502019 @default.
- W4253347950 countsByYear W42533479502020 @default.
- W4253347950 countsByYear W42533479502022 @default.
- W4253347950 crossrefType "journal-article" @default.
- W4253347950 hasAuthorship W4253347950A5011733008 @default.
- W4253347950 hasAuthorship W4253347950A5020913751 @default.
- W4253347950 hasAuthorship W4253347950A5025297677 @default.
- W4253347950 hasAuthorship W4253347950A5040757424 @default.
- W4253347950 hasAuthorship W4253347950A5067522555 @default.
- W4253347950 hasConcept C104317684 @default.
- W4253347950 hasConcept C125418893 @default.
- W4253347950 hasConcept C129312508 @default.
- W4253347950 hasConcept C153911025 @default.
- W4253347950 hasConcept C185592680 @default.
- W4253347950 hasConcept C186852380 @default.
- W4253347950 hasConcept C2776993315 @default.
- W4253347950 hasConcept C2993175405 @default.
- W4253347950 hasConcept C38441620 @default.
- W4253347950 hasConcept C42362537 @default.
- W4253347950 hasConcept C552990157 @default.
- W4253347950 hasConcept C55493867 @default.
- W4253347950 hasConcept C62478195 @default.
- W4253347950 hasConcept C67705224 @default.
- W4253347950 hasConcept C79879829 @default.
- W4253347950 hasConcept C86803240 @default.
- W4253347950 hasConceptScore W4253347950C104317684 @default.
- W4253347950 hasConceptScore W4253347950C125418893 @default.
- W4253347950 hasConceptScore W4253347950C129312508 @default.
- W4253347950 hasConceptScore W4253347950C153911025 @default.
- W4253347950 hasConceptScore W4253347950C185592680 @default.
- W4253347950 hasConceptScore W4253347950C186852380 @default.
- W4253347950 hasConceptScore W4253347950C2776993315 @default.
- W4253347950 hasConceptScore W4253347950C2993175405 @default.
- W4253347950 hasConceptScore W4253347950C38441620 @default.
- W4253347950 hasConceptScore W4253347950C42362537 @default.
- W4253347950 hasConceptScore W4253347950C552990157 @default.
- W4253347950 hasConceptScore W4253347950C55493867 @default.
- W4253347950 hasConceptScore W4253347950C62478195 @default.
- W4253347950 hasConceptScore W4253347950C67705224 @default.
- W4253347950 hasConceptScore W4253347950C79879829 @default.
- W4253347950 hasConceptScore W4253347950C86803240 @default.
- W4253347950 hasIssue "12" @default.
- W4253347950 hasLocation W42533479501 @default.
- W4253347950 hasOpenAccess W4253347950 @default.
- W4253347950 hasPrimaryLocation W42533479501 @default.
- W4253347950 hasRelatedWork W1968236591 @default.
- W4253347950 hasRelatedWork W2033461855 @default.
- W4253347950 hasRelatedWork W2034979205 @default.
- W4253347950 hasRelatedWork W2039257831 @default.
- W4253347950 hasRelatedWork W2069307743 @default.
- W4253347950 hasRelatedWork W2075970822 @default.
- W4253347950 hasRelatedWork W2164314366 @default.